As of 4:14pm ET
| -1.22 / -1.50%|
The 22 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 84.50, with a high estimate of 96.00 and a low estimate of 65.00. The median estimate represents a +5.69% increase from the last price of 79.95.
The current consensus among 29 polled investment analysts is to Hold stock in Gilead Sciences. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.